In a previous cohort profile we described the Doetinchem Cohort Study from round one starting in 1987-91 as a monitoring study, and its development into a cohort study with a second measurement in 1993-97 and a third in [1998][1999][2000][2001][2002]. 1 The original sample was an age-sex-stratified sample of the population register of inhabitants of Doetinchem, with equal numbers of men and women and equal numbers in 10-year age categories: 20-29, 30-39, 40-49 and 50-59. In the first round the focus was on cardiovascular health, and this was broadened to other major chronic conditions in the second round. The Doetinchem Cohort Study is carried out by the Dutch National Institute for Public Health and the Environment.
What is the reason for the new data collection?
The study continued into a fourth round (2003-07) and a fifth round , and now a sixth round (2013-17) is ongoing. From round four onwards we expanded the measurement protocol even further with research themes to serve current public health research questions on lifestyle, chronic diseases and ageing. The Doetinchem Cohort covers a large part of the life course from young adulthood to old age because the initial general population sample aged between 20 and 59 years has been followed for more than 25 years, and is currently between 46 and 85 years.
What will be the new areas of research?
First, with extension of the period of data collection, the cohort is increasingly used for research questions on changes over the life course and in particular while ageing. This refers to changes in lifestyle, biomarkers, health and disease and the relations between them. Second, the traditional risk factors for chronic conditions can now be studied in relation to new measures such as sleep, muscle strength, loneliness and depressive symptoms. Third, the availability of biomaterial in every round (including DNA) gives numerous research possibilities (including epigenetic analyses). Fourth, having such an infrastructure gives also the possibility to add side studies. Some of our participants participated in a study on 24-h urine collection for salt consumption, 2 a pilot study for a new Food Frequency Questionnaire or a study on immunosenescence, which required extra blood collection.
Who is in the cohort? Table 1 presents the numbers invited and measured in the different rounds and Figure 1 presents a flow chart. In In the year 1992, no measurements were carried out: in this year preparation for the next measurement (protocol development) was carried out.
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Of those participating in round 1, a sample was drawn for round 2. 
What has been measured?
From the start, standard themes and measurements related to chronic diseases were included with special attention to cardiovascular diseases, diabetes, musculoskeletal disorders, respiratory diseases and cancer. These have all been continued during later rounds, including the collection of blood. From round 4 onwards we expanded the measurement protocol and we have added measurements related to ageing, such as functioning and frailty, and to emerging public health topics, such as shift work. Box 1 gives an overview of the measurements in rounds 5 and 6. These new measurements are described below as well as information on the biobank.
New measurements during the physical examination
In rounds 5 and 6 we added a number of items that are relevant for the study of healthy ageing and frailty. Muscle strength was measured through hand grip strength (HGS) of the preferred hand by means of a hydraulic hand-held dynamometer (Jamar) in the sitting position. We also included the timed chair stand test 3, 4 and the balance test as additional indicators of physical functioning. For osteoporosis we measured fracture history and also heel bone mass using quantitative ultrasound (QUS) measurements with a Hologic Sahara bone densitometer (Hologic Inc., USA). Hypertension is mean systolic blood pressure ! 140 and/or mean diastolic blood pressure ! 90 or using blood pressure-lowering medication. f Self-reported diabetes mellitus, cancer, myocardial infarction or cerebral vascular accident (CVA).
Physical activity is a key topic for prevention and ageing research, and as well as the extensive questionnaire we used for many years, we added in round 6 the Actigraph GT3Xþ, 5 for the more objective measurement of physical activity. The Actigraph measures accelerations on three axes (tri-axial) to assess the frequency, duration and intensity of PA over time. Participants wear the Actigraph nonstop for 7 days. A small diary was added with questions on wake-up time, non-wearing time and reasons for it and time spent on biking (and whether an ebike was used).
In human nutrition and biology, advanced glycation end products, known as AGEs, are substances that can be a factor in ageing and in the development or worsening of many degenerative diseases, such as diabetes, atherosclerosis, chronic renal failure and Alzheimer's disease. 6 In order to contribute to this research we added a non-invasive measurement which measures AGEs in the skin of the arm by means of fluorescence techniques [skin autofluorescence (skin AF)] using the AGEs reader made by Diagnoptics Technology, The Netherlands.
New themes in questionnaires
The main themes for which the questionnaires have been extended are as follows.
Sedentary behavior. The measurement of physical activity has traditionally been focused on time spent on specific activities as walking, sports, gardening and biking. Evidence is accumulating that sedentary behavior-the other end of the physical activity continuum-has an effect on health that is independent from physical activity. 7 We added questions on time spent sitting separately for transportation, work, computer activities and watching television.
Shift work. Long-term exposure to shift work may influence health, so we included a series of questions on lifetime exposure to shift work, measuring major domains of shift work that have been identified by the international consensus report by Stevens et al., 8 i.e. shift system, cumulative exposure and shift intensity.
Health care, self-care, informal care. We measured use of health care: contact with a variety of health care professionals (including GP, medical specialists, dentist, physiotherapist, home care worker, psychologist etc.), similar to usual monitoring of health care use in The Netherlands. In addition we included questions on receiving and providing informal care, and types of and problems with self-care, using the Patient Assessment of Self-management questionnaire (PAST). Oral health. Oral health is affected by ageing and is also associated with several chronic diseases. We used a number of questions to assess the condition of teeth and gums, and tooth brushing habits.
Health literacy. Health literacy is defined as the degree to which people are able to access, understand, appraise and communicate information to engage with the demands of different health contexts to promote and maintain health across the life course. We included the often-used screening questionnaire as developed by Chew et al.
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Perception of living environment. This was measured for physical activity (e.g. availability of specific sports facilities), the perception of safety and nature areas, and the exposure to noise pollution. Also we measured historical exposure to noise at work.
Biobank samples and measures
A total of 25 ml of non-fasting venous blood is collected in every round using three types of vacutainers: NaF, serum and EDTA. Samples are centrifuged and aliquoted in 25 cryovial tubes, including plasma, serum, erythrocytes and buffy coat. Standard storage is at -80˚C. Blood samples are available for all participants for all rounds, though there are some differences per measurement round referring to storage conditions (in round 1 only -20˚C, and additional -196 C storage in round 2 only) or number of tubes. Total cholesterol and HDL cholesterol were measured until 1998 in non-fasting EDTA-plasma, and from 1998 onwards in serum at the Lipid Reference Laboratory of Erasmus Medical Center (former University Hospital Dijkzigt) in Rotterdam, using standardized enzymatic methods. Random plasma glucose was measured with the hexokinase method. 16 From round 5 onwards we took spot urine samples and stored those at À80 C, after testing the sample for urinary tract infection. In 2012 we measured several biochemical markers using all available samples of rounds 1 through 5 for each participant. Such single-run measurement maximally reduces inter-assay variation. 17 Measures included gamma-glutamyltransferase (GGT), uric acid, triglycerides (GPO-PAP assay), alanine aminotransferase (ALT) (kinetic UV assay), high sensitivity C-reactive protein (CRP), cystatin C and creatinine.
In 2017 all participants with a least three rounds of examination will be included in a genome-wide association study (GWAS).
What has it found? Key findings and publications
As the original focus was CVD, many studies were published on cardiovascular diseases. [18] [19] [20] [21] [22] With a view over a substantial part of the life course of adults, the research questions have been extended yo life course and ageing topics. These research questions relate to changes in lifestyle over the life course 23 and whether these changes are related to health outcomes. 19, 24 We focus also on the analyses of the course of health characteristics over time [25] [26] [27] and the determinants of changes in health, e.g. cognitive decline. [28] [29] [30] [31] [32] We are also interested in the differences between generations. 33, 34 Examples of research using our extensive biobank focus on changes in metabolic risk factors over the life course 35 and renal on function. 36 We also participate in genetic studies. 37, 38 Round 2 of the Doetinchem Cohort Study was part of the international EPIC study, 39, 40 and of the spin-off projects on diabetes (EPIC-Interact) 41 and cardiovascular disease (EPIC-CVD). 42 Cooperation with other studies includes meta-analyses. 43 We also used data from the Doetinchem Cohort Study with many other Dutch studies to give the best estimates for disability in Dutch population. 44, 45 Together with the Longitudinal Ageing Study Amsterdam, 46 we analysed the prevalence of smoking for a broad range of generations. 47 The Doetinchem Cohort Study is also used as a 'normal comparison' for clinical samples, for instance a cohort of patients with rheumatic diseases. 48 Some key measurements (blood pressure, blood lipids, body weight, smoking) of the participants in round 5 are presented by sex in Table 3 .
What are the main strengths and weaknesses?
The main strengths of the Doetinchem Cohort Study are: (i) long-term follow-up of randomly selected individuals of a broad age range; (ii) extensive characterization of lifestyle (including nutrition) and health and disease, including lung function, biological material (extensive biobank, including DNA in every round) and cognition in every round; and (iii) the linkage to data from many registries, e.g. cause of death, hospital registries, pharmacy records and cancer registries.
The main weaknesses are: (i) the limited size of the cohort for infrequent health problems; (ii) the lack of ethnic subgroups; and, due to financial limitations, (iii) we were not able to sample new cohorts from the younger age categories during follow-up.
The main challenges we face in carrying out the study refer to attrition and financing of the study. Participating in the physical examination and filling out questionnaires become a bigger challenge, with the longer follow-up of the study. Participants may not like to notice that they are doing worse compared with 5 years earlier. This is in particular a challenge for re-running the cognition measurements. We particularly want to prevent participants from dropping out of the study when they become frail.
We are in the privileged position of having been able to carry out this study already for 30 years. However, continuation of the study with a 7th measurement round, the maintenance of the biobank with samples from all previous rounds, and the more complex organization of carrying out the study with increasingly expanding topics, as well as finding funding for harvesting these rich data, remain a challenge.
Can I get hold of the data? Where can I find out more?
We welcome collaboration with other researchers. Several types of collaboration to exploit the data are possible. Please contact: Professor WMM Verschuren, [monique. verschuren@rivm.nl]. 
Cohort Profile Update in a nutshell
• Originated from a monitoring study on cardiovascular disease risk factors, the Doetinchem Cohort study has been expanded to a study on lifestyle and other determinants of chronic conditions and ageing, with individual data covering 25 years.
• In 1987 it started with an age-sex-stratified sample • Two-thirds of those measured at baseline (n ¼ 7768)
were invited for first follow-up measurement in
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